How Much Does Ketamine Therapy Cost?
By Michael Alvear, Health Author & Independent Researcher
My research is published on these scholarly platforms:
Last Updated:
Ketamine Therapy Costs By Treatment Route
We show median numbers because cost variability is so extreme that ranges become overwhelming—the median represents what a typical person in a typical city actually pays.
| Treatment Option | Cost Per Treatment (Median) | # of Treatments | Total Cost (Median) | Notes |
|---|---|---|---|---|
| Spravato (No Insurance) | $1,050/session | 21 | $22,050 | Self-pay pricing varies by clinic. 21 sessions is the standard FDA protocol for the first 6 months. |
| Spravato (With Insurance Only) | $286/session | 21 | $6,000 | Based on typical insurance: $2,000 deductible, $6,000 out-of-pocket max, 20% coinsurance. Costs can shift dramatically based on your plan. 21 sessions is the standard FDA protocol for the first 6 months. |
| Spravato (Insurance + Manufacturer Subsidy) | $135/session | 21 | $2,835 | Assumes typical insurance plus manufacturer copay support for eligible patients. 21 sessions is the standard FDA protocol for the first 6 months. |
| IV Ketamine | $590/infusion | 15 | $7,975 | Number of infusions ranges from 11 to 18 depending on each individual—we chose 15 as a typical acute + early maintenance course based on common clinic protocols. |
| Injection (IM) Ketamine | $425/injection | 15 | $4,675 | Number of injections ranges from 11 to 18 depending on each individual—we chose 15 as a typical acute + early maintenance course based on common clinic protocols. |
| Oral/Sublingual Ketamine – Prescription from psychiatrist/physician | ~$75–$200 per fill (≈1 month) | No standard course | Open-ended* | Public schedules show compounding pharmacy per-unit pricing with a $50 minimum and common strengths of 100–200 mg per troche. A fill usually covers about a month of doses, but there is no agreed-upon number of months, so total cost depends entirely on how long you and your prescriber continue. Warning! The FDA warns against using compounded ketamine outside supervised settings. |
| Oral/Sublingual – Daily Micro-Dosing (Telehealth services like Joyous) | ~$129/month subscription | No standard course | Open-ended* | Low daily doses (≈10–20 mg/day) shipped as a bundle with app/check-ins; commonly advertised at ~$129/month. Studies of oral ketamine use short windows (4–6 weeks), but micro-dose programs explicitly say there is no set timeline and many patients stay on for months or years, so there is no honest “total” cost. Warning! The FDA warns against using compounded ketamine outside supervised settings. |
| Oral/Sublingual – Session-Based (At-Home Telehealth services like Mindbloom) | ~$90–$200 per at-home session | Blocks of 4–8+ sessions | Open-ended* | Telehealth brands sell finite blocks (e.g., 4 Wondermed doses, 6 Mindbloom sessions, 8 Innerwell sessions) at roughly $90–$200 per session, then encourage ongoing “healing journeys” or additional packages. There is no consensus on how many at-home oral ketamine sessions count as induction, maintenance, or extended maintenance, and no trial data on multi-year courses, so real-world total cost is structurally open-ended. Warning! The FDA warns against using compounded ketamine outside supervised settings. |
Table Notes on Oral & Sublingual
There are no FDA-approved schedules or professional guidelines that define how many doses or sessions a “full course” should include. Published trials use short, fixed windows, while real-world programs often run as subscriptions or repeating blocks with no clear stopping rule. Long-term total cost (and long-term safety) depends entirely on how long you and your prescriber decide to continue.
Table Notes on IV, Injection & Spravato
Costs vary widely by city size and by how generous your insurance is—especially where you are in your deductible and out-of-pocket maximum. That’s why we use the median—the middle value where half of prices are higher and half lower. It’s a realistic planning number: expect lower costs in smaller cities like Des Moines and higher in major metros like New York City.
Got Questions? Ask Me Directly.
Got Questions? Ask Me Directly.
Can’t Decide Between IV, Injections, Or Spravato?
Use My Decision Table
This report ranks all three options—IV, injection, and Spravato—on effectiveness, cost, fastest relief, and more, giving you a clear framework to decide.
Downloads as PDF • 5 minute read
What Are The Real Costs Of Ketamine Therapy?
See exact median costs for IV, injection, and Spravato treatments
Over the course of six months, a full protocol of ketamine therapy can cost anywhere from $0 to over $27,000. It all depends on your delivery method—IV, injection, or Spravato nasal spray—along with how much help you get from insurance, what kind of plan you have, and whether you qualify for the Spravato manufacturer subsidy. This section shows what people actually pay across all those scenarios.
You’ve heard ketamine might help when nothing else has. Maybe you’ve tried antidepressants, maybe you’ve tried everything. But now you’re stuck on a more immediate question: what is this going to cost—and can I afford it if it works?
The answer depends on a few big factors: whether you’re using Spravato (the nasal spray), IV infusions, or injections—and whether you have commercial insurance that covers any of it. This table gives you a full view of what most people pay for a complete round of treatment.
| Treatment Type | Cost Per Treatment | Number of Treatments | Total Cost Range | Median Total Cost |
|---|---|---|---|---|
| IV Ketamine (Insurance Won’t Cover It) |
$425–$750 | 11–18 | $4,675–$13,500 | $7,975 |
| Injection Ketamine (Insurance Won’t Cover It) |
$300–$550 | 11–18 | $3,300–$6,050 | $4,675 |
| Spravato Nasal Spray (Self-Pay, No Insurance) |
$800–$1,300 | 21 | $16,800–$27,300 | $22,050 |
| Spravato Nasal Spray (With Commercial Insurance) |
$140–$450 | 21 | $2,940–$9,450 | $6,195 |
| Spravato Nasal Spray (With Insurance + Manufacturer Subsidy) |
$0–$62 | 21 | $0–$1,300 | $650 |
| Oral/Sublingual (Not covered by insurance) |
See notes below | See notes below | See notes below | See notes below |
Why Oral & Sublingual Ketamine Aren’t in This Cost Table
You might notice that oral and sublingual ketamine aren’t listed alongside IV, injections, and Spravato in this “total cost” table—even though we have data on their per-dose pricing.
The problem is not the price of a single dose; it’s the complete lack of agreement about how many doses make up a “course” of treatment. Research trials use short, fixed schedules (for example, a handful of doses over a few weeks), while many telehealth programs and compounded-prescription practices treat oral and sublingual ketamine more like an ongoing subscription—with no clear end date and highly variable dosing schedules.
If we forced oral/sublingual rows into this table, any “total cost” number for six months would be more guess than fact. Instead of pretending the protocol is as standardized as IV, injections, or Spravato, we handle oral and sublingual ketamine in a separate section, where we can talk honestly about why the number of treatments—and therefore the real cost—swings so widely from one person to the next.
As you’ll see in the sections ahead, the difference between getting help and getting priced out often comes down to what type of ketamine you’re using—and what kind of support system is (or isn’t) in place. For some people, it’s manageable. For others, it’s completely out of reach.
Keep going. We’ll break down each of these scenarios, starting with the most expensive one: paying for everything out of pocket.
What If I Have To Pay For Treatment Myself, Without Any Insurance?
Understand out-of-pocket costs and what to expect
If you’re paying 100% out of pocket for a 6-month full protocol, ketamine therapy injection is the most affordable ($3,300–$6,050), followed by IV ketamine ($4,675–$13,500). Spravato is by far the most expensive ($16,800–$27,300) because it requires more sessions and is priced as a specialty drug.
For a lot of people, this is the default scenario—especially if you’re considering IV or injection ketamine. Insurance doesn’t cover them. Medicare doesn’t cover IV/injection either. And even though Spravato is FDA-approved, many plans won’t touch it unless you’ve already failed multiple antidepressants and can prove it in writing.
That means you’re stuck paying the full amount yourself. No reimbursement. No partial coverage. No help.
This table shows what that actually looks like across the three main treatment types. These are real numbers, based on full self-pay prices with no insurance and no manufacturer assistance. It’s not pretty. But it’s what many people are facing.
Why Oral/Sublingual Ketamine Isn’t Included In This Table
There’s no FDA-approved protocol, no official schedule, and no professional guideline that says, “You should get X oral doses or Y sublingual sessions.”
Because there’s no agreed-upon number of treatments or duration, we can’t include them in this table; instead, you’ll find per-dose and package pricing from ketamine telehealth services here.
Note: research on oral/sublingual ketamine so far shows modest but still inconclusive benefit, with higher uncertainty and risk than better-studied routes. The FDA has issued multiple safety alerts warning that using compounded ketamine outside a monitored clinical setting can be dangerous.
That doesn’t mean you shouldn’t consider oral or sublingual ketamine at home—it means you need to go in with eyes open about the risks, trade-offs, and unknowns. I’m laying this out so you have the full picture and can make a truly informed decision with your clinician; if you want to go deeper, my Guide to Oral Ketamine walks through every major decision point—troche vs rapid-dissolve tablet, the “spit or swallow” absorption shortcut, where many people start on milligrams, and what we actually know about side effects and effectiveness.
Spravato is clearly the most expensive option when you’re paying out of pocket—because it requires more sessions (21) and the drug itself is priced as a specialty medication. IV ketamine is usually cheaper, but it still adds up fast. Injection therapy is the lowest-cost method, but fewer clinics offer it and you’ll likely have less medical monitoring built in.
The big thing to keep in mind is this: these aren’t optional costs. If ketamine is working, most people need at least a dozen treatments—sometimes more. And if you’re paying cash, there’s no fallback. If you can’t continue, you stop. That’s the risk people take when cost becomes the barrier between them and relief.
Detailed Breakdown: Spravato Esketamine Nasal Spray Cost Per Session Without Insurance
Understanding the financial commitment of Spravato treatment goes beyond just counting sessions. For patients considering self-pay options or wondering what costs look like before insurance, pricing transparency is essential. The following section provides comprehensive information about what each Spravato session typically costs across different regions, dosages, and clinic types.
▶ Click Here To See Spravato (Esketamine) Self-Pay Treatment Costs Per Session
Spravato is administered in a certified clinic under medical supervision, and self-pay patients must cover both the drug cost and the clinic’s monitoring fee for each session. Below is a breakdown of typical out-of-pocket costs in the U.S. for the two available dosages (56 mg and 84 mg), along with national averages and range estimates.
Cost per Session – 56 mg Dosage
- Medication List Price: The manufacturer’s list price for a 56 mg Spravato dose (two 28 mg nasal spray devices) is about $590. This is the base cost of the drug alone (wholesale acquisition cost).
- Clinic/Monitoring Fees: Clinics charge additional fees for the required observation (at least 2 hours post-dose). Facility monitoring fees typically run about $200–$400 per session for self-pay patients , though this can vary.
- Typical Self-Pay Price Range: In practice, a cash-paying patient can expect to pay roughly $600 to $900 per session for a 56 mg treatment when medication and clinic fees are combined. Some clinics quote ~$590 (just covering the drug at cost) up to around $725 for 56 mg, but others may charge closer to $800 or more once all fees are included.
- National Average: The average out-of-pocket cost for one 56 mg Spravato session is around $700–$800 (midpoint of the typical range) in many areas. This assumes no insurance or assistance offsets. In high-cost urban areas or hospital settings, the 56 mg session might trend toward the upper end (around $900 or slightly higher), whereas in lower-cost regions some clinics keep it closer to the base $600–$700 level.
Cost per Session – 84 mg Dosage
- Medication List Price: The list price for an 84 mg Spravato dose (three 28 mg devices) is approximately $885 for the drug itself. This higher dose uses an extra device, increasing the medication cost.
- Clinic/Monitoring Fees: Monitoring and administration fees for an 84 mg session are usually similar to those for 56 mg (around $200–$400 per session for self-pay). The clinic’s charge may not differ greatly by dose, but the longer administration (more devices) and higher drug cost make the total higher for 84 mg.
- Typical Self-Pay Price Range: $800 to $1,300 is a typical range per session for the 84 mg dose, medication + monitoring included. Many clinics charge on the order of $720–$900 for an 84 mg treatment, but some report totals above $1,000. One analysis notes uninsured 84 mg sessions can run about $900 on the low end up to $1,300 at the high end.
- National Average: The average cost for a self-pay 84 mg session is roughly $1,000–$1,100. In other words, most U.S. patients paying cash face around a thousand dollars per 84 mg treatment. Costs near the lower end (~$800–$900) are seen at some clinics, but higher-cost settings frequently charge $1,100+ for this larger dose.
Regional and Clinic Variations
Pricing can vary by geographic region and clinic type:
- Clinic Type: Academic medical centers or hospital-based programs often have higher overhead, which can translate to higher facility charges. These centers may price sessions toward the top of the range (e.g. for 84 mg, around $1,200+ per session). In contrast, private outpatient psychiatric clinics or dedicated ketamine centers might offer slightly lower cash rates, closer to the medication’s wholesale cost plus a modest fee. For example, some independent clinics charge roughly the list price of the drug ($590/$885) plus a small monitoring fee, keeping 56 mg sessions near the $600–$700 level and 84 mg sessions around $900.
- Region: High cost-of-living regions (major cities like NYC, Los Angeles, etc.) tend to have higher personnel and facility costs, so self-pay Spravato prices in these areas often skew high (the upper end of the national range). Conversely, clinics in smaller cities or regions with lower medical costs may charge nearer to the lower end. Still, because the drug itself has a fixed price nationwide, even in cheaper regions the floor is set by that medication cost. In all areas, the required 2-hour monitoring imposes a baseline expense for staffing and space. As a result, most U.S. clinics – regardless of location – report per-session prices in a fairly high band (generally no less than ~$600–$700 and up to $1,200–$1,300) for Spravato therapy.
Summary of Self-Pay Prices (Per Session)
- 56 mg dose: Approximately $700 on average, with a typical range from about $600 up to $900 for one treatment session (drug + clinic fees)
- 84 mg dose: Approximately $1,000 on average, with a broader range roughly $800 up to $1,300 per session (all-inclusive)
These estimates represent national average conditions for cash-paying patients. Keep in mind that individual clinics may quote different prices: for instance, one Colorado clinic notes the medication alone costs $700–$1,200 depending on dose (56 vs 84 mg), and that does not include the monitoring fee. Always confirm with the specific treatment center, as some may bundle the observation charge into one price while others bill the drug and facility fee separately.
Caveats: Spravato is deliberately expensive, and most patients utilize insurance coverage or manufacturer support programs to defray costs. The figures above assume no insurance coverage and no manufacturer discounts – a true 100% out-of-pocket scenario. In reality, Janssen’s Spravato withMe program can reduce costs for insured patients (e.g. copays as low as $10 with commercial insurance), and there is a patient assistance program for eligible uninsured individuals. But without any such assistance, a person should be prepared for the substantial costs per session outlined above.
Sources: Pricing data is drawn from published reports and clinic guides. Notably, Janssen’s wholesale list prices (~$590 for 56 mg, $885 for 84 mg) are widely cited. Out-of-pocket pricing guides and clinic resources indicate real-world self-pay charges in the ranges given. These ranges account for both the esketamine drug cost and typical U.S. clinic fees, providing a reasonable national benchmark for Spravato session pricing with no insurance.
What If My Insurance Actually Covers Spravato? How Much Would I Pay Then?
Calculate your actual costs with insurance coverage
If your commercial insurance plan covers Spravato, your out-of-pocket costs can drop significantly—but they don’t disappear. What you’ll pay depends on your deductible, coinsurance, and whether any facility fees are billed separately. The table below shows what most insured patients actually spend over the full 21-session protocol, before any manufacturer discounts are applied. Does Medicare cover ketamine therapy? Technically, yes (Spravato only) but there’s a 24-state desert where no billing appears suggesting there are structural impediments preventing people from accessing it. We see similar ketamine therapy policies with Medicaid.
If you have commercial insurance and your plan covers Spravato, the costs can drop dramatically—but it’s not always straightforward. Even when it’s “covered,” you’re still on the hook for copays, coinsurance, and sometimes facility fees.
This table shows what most patients pay out of pocket when insurance is covering Spravato, but without manufacturer subsidy. The range reflects real billing patterns across dozens of clinics, using the full 21-session FDA-required protocol.
The median out-of-pocket cost for insured Spravato patients is around $6,195. But depending on your deductible and plan design, it could be as low as $2,940 or as high as $9,450. In other words, even with insurance, some patients still pay more than they would for IV ketamine out of pocket.
Also keep in mind: Spravato requires 21 visits, each lasting about two hours. That’s 21 days off work. 21 rides to and from the clinic. 21 chances to get hit with a facility or monitoring fee that’s billed separately from the drug itself.
Insurance coverage helps—but it doesn’t guarantee affordability. And getting approved can be a process. In the next section, we’ll show you what happens if you qualify for both insurance and the manufacturer subsidy program.
Takeaway:
Even with insurance, many Spravato patients pay $6,000 or more out of pocket—sometimes more than they’d pay for IV ketamine without insurance. That’s because coverage doesn’t eliminate deductibles, copays, or clinic-based fees and Spravato can require up to double the sessions compared to IV.
How Much Would I Pay If I Qualified For The Manufacturer’s Subsidy?
Learn about Janssen’s assistance program and savings
Spravato’s subsidy covers up to $8,150, reducing your per-session cost to $0–$62 and your total for the full 21-session protocol to just $0–$1,300–depending on your plan’s co-pays and deductibles. However, you must have commercial insurance, not Medicare, Medicaid, or VA—and you still need prior authorization. If you meet those conditions, this is the cheapest way to access ketamine therapy in the U.S.
If you qualify for Spravato’s assistance program, your out-of-pocket costs can drop dramatically. The manufacturer, Janssen, offers up to $8,150 in savings for eligible patients with commercial insurance. That can bring your per-session cost down to almost nothing—sometimes as low as $0, with a cap of $62 per visit.
Here’s what that looks like across a full course of treatment:
In this best-case scenario, Spravato becomes by far the most affordable option—if you qualify. But that’s a big “if.” To qualify for the subsidy, you must:
- Have commercial (non-government) insurance
- Not be using Medicare, Medicaid, or VA coverage
- Be approved for Spravato through your insurer’s prior authorization process
For patients who need Spravato and have insurance, it’s worth applying. You can find the program details here.
Next we’ll look at why IV and injection ketamine—despite being widely used—are almost never covered by insurance.
What Other Costs Should I Expect Besides The Treatment Itself?
Intake fees, monitoring charges, rides to the clinic, time off work, even childcare are all costs you need to consider. Add them up across 6 months of ketamine therapy, and they can derail your budget fast. This section shows you what to expect so you’re not blindsided halfway through your plan.
Even when you think you’ve got the treatment cost figured out, other expenses can sneak up on you. Here are the most common hidden costs you should plan for:
Consultation and Intake Fees
Many clinics charge $150–$500 for the initial evaluation. This is separate from your first treatment session, and it’s not always applied to future visits.
Monitoring Fees
Some clinics bill separately for nurse supervision, vital sign tracking, or post-session recovery. These fees can run $25–$100 per visit, especially for Spravato.
Transportation
For IV, injection, and Spravato, you won’t be allowed to drive home. That means 11–21 rides depending on your protocol. Even at $30 per Uber, that’s hundreds of dollars out of pocket if you don’t have a ride.
Time Off Work
Each treatment takes 1–2 hours plus recovery time. You may miss an entire workday—especially with Spravato. If you don’t have PTO, that’s lost income every week.
Childcare
Some patients have to arrange paid childcare during treatment hours. Even a few hours per week adds significant cost across a 6 month protocol.
Maintenance Treatments
Most people don’t stop at the induction phase. You may need boosters every 2–6 weeks to stay stable. That means the costs keep coming, even after you “finish” treatment.
The smartest financial decision isn’t always the cheapest one—it’s the one that gives you back your ability to earn, function, and build a future worth living.
How Did You Come Up With These Numbers—And Can I Trust Them?
Our pricing data comes from 10 small, 10 medium, and 10 large markets nationwide, using population-weighted analysis and interquartile range filtering to eliminate outliers and reflect realistic ketamine treatment costs.
These numbers weren’t pulled out of thin air. We built them from the ground up using real pricing from 30 ketamine clinics across the country—10 in small markets, 10 in mid-sized cities, and 10 in large urban areas.
For IV ketamine and injection therapy, we collected prices from clinics in rural Florida, small towns in Texas and Georgia, mid-sized cities in Colorado and Massachusetts, and major metros like New York, LA, and Chicago. Prices ranged from as low as $275 per session in small towns to over $1,500 in high-end urban clinics.
Population-Weighted Model
Instead of treating each clinic equally, we used a population-weighted model based on U.S. census distribution:
- 20% of the population in small/rural markets
- 30% in mid-sized/suburban areas
- 50% in large cities
That weighting gave us a national cost range of about $400–$1,000 per IV ketamine session. But that’s still too broad to be useful for most patients, so we narrowed it using the interquartile range (IQR)—a statistical method that excludes outliers and focuses on the middle 50% of prices. That gave us a more grounded and realistic range: $425–$750 per session.
Treatment Session Counts
To estimate total treatment costs, we applied that IQR range to a session count of 11 to 18 treatments. That’s based on real-world clinical protocols: patients typically start with 6–8 infusions in the first few weeks, then taper down over months 2 to 6. This model reflects not just induction, but stabilization and maintenance through the first 6 months of care.
We did the same for injection ketamine, which tends to be $100–$200 cheaper per session than IV infusions. Fewer clinics offer it, but when they do, the pricing tends to fall between $300–$550. We applied the same 11–18 session model for consistency and comparability.
Spravato Required a Different Approach
Because it’s FDA-approved, it follows a fixed protocol: two sessions per week for the first month, then weekly or biweekly after that. The full 6-month protocol includes at least 21 sessions, which we used for all cost modeling.
We created three separate scenarios for Spravato:
Self-pay: No insurance, no discounts. This reflects the true sticker price of $800–$1,300 per session, for a total of $16,800–$27,300.
Commercial insurance: Typical coverage with copays and coinsurance, based on real-world billing ranges of $140–$450 per session.
Insurance plus manufacturer subsidy: For patients who qualify for Janssen’s assistance program, which can reduce the per-session cost to as low as $0–$62, up to a maximum benefit of $8,150.
We also calculated median costs for each scenario—but we’re careful about how we present them. A median of $6,195 for insured Spravato treatment might sound reassuring, but the top end is still $9,450. That’s why we always show both the range and the median side by side: so you don’t mistake “typical” for “guaranteed.”
Bottom line: this is the most complete national pricing model we know of for ketamine therapy. It’s not perfect—but it’s honest, transparent, and built to help you plan instead of panic.
Takeaway: Our analysis draws from 30 U.S. markets (not individual clinics), using population weighting (20% small, 30% mid-sized, 50% large), statistical filtering, and actual protocol counts—11–18 sessions for IV/injection, 21 for Spravato. We modeled three Spravato scenarios: self-pay ($800–$1,300/session), insured ($140–$450/session), and with manufacturer subsidy ($0–$62/session).
Why Won’t My Insurance Cover IV Or Injection Ketamine?
Understand insurance limitations and off-label challenges
Insurance won’t cover IV or injection ketamine for depression because the FDA hasn’t approved them for that purpose. Not because they’re unsafe. Not because they’re ineffective. But because they’re generic, off-patent, and no company has paid to sponsor them through the FDA’s expensive approval process. That’s the real reason coverage is denied—even though IV ketamine has outperformed nearly every antidepressant ever tested. This section explains why the FDA won’t act on overwhelming evidence unless it comes with a corporate sponsor—and how that failure shapes what patients can access, afford, or even consider.
This is one of the most frustrating parts of ketamine therapy: the most widely used forms—IV and injection—aren’t covered by insurance. Not because they don’t work. Not because they’re unsafe. But because they’re not FDA-approved for depression.
The irony? IV ketamine has outperformed nearly every antidepressant ever tested. Decades of studies show it can relieve suicidal depression in hours—not weeks—and work when nothing else does. So why hasn’t the FDA approved it?
Because ketamine is old, cheap, and off-patent. There’s no company with a financial incentive to sponsor it through the FDA’s billion-dollar approval process. And that process doesn’t reward what already exists—it rewards what can be packaged, patented, and sold.
Spravato, the nasal spray version of ketamine, got FDA approval in 2019 not because it works better, but because it’s a new enough “formulation” to qualify for commercial exclusivity. It’s ketamine’s left hand—just one half of the full compound—delivered through a nasal spray instead of an IV. That made it novel enough to patent. And profitable enough to fund clinical trials.
IV ketamine? It’s generic. It’s decades old. And it’s already widely available. No one can own it. Which means no one can make enough money on it to justify spending the hundreds of millions it takes to get FDA approval.
That’s not science. That’s a structural flaw in the approval system.
The FDA doesn’t have a pathway for drugs with overwhelming independent evidence but no commercial sponsor. It can’t accept meta-analyses. It doesn’t recognize the success of hundreds of published trials unless they’re part of a specific, company-funded application. So even though IV ketamine has been tested in more than 80 randomized controlled trials, it still sits outside the system—off-label, unfunded, and uncovered by insurance.
This isn’t just a paperwork issue. It’s a matter of access, cost, and survival. Patients are being forced into the most expensive version of a drug while cheaper, more effective forms are ignored. Doctors are boxed into prescribing what insurance will reimburse, not what research supports. And people who might finally find relief with IV ketamine are left without options unless they can pay out of pocket.
There’s a way forward. The FDA could create a separate approval track for therapies with substantial independent evidence. It could evaluate safety and efficacy using peer-reviewed research instead of waiting for a pharmaceutical company to rewrite the rules. It could finally approve what the science has already confirmed: IV ketamine saves lives.
Until then, patients will keep paying more for less—and wondering why a treatment that could change everything is still stuck behind the wrong set of rules.
IV ketamine isn’t covered because no company can profit from it—and the FDA has no system for approving treatments based on independent evidence alone. That leaves the most effective version of ketamine therapy locked out of insurance coverage, despite decades of research and real-world results.
How Can I Lower The Cost If I’m Paying Out Of Pocket?
Discover strategies to reduce your treatment expenses
Paying out of pocket for ketamine therapy doesn’t always mean paying full price. Clinics rarely advertise it, but many offer discounts—if you know how to ask. From package deals and off-peak slots to income-based pricing and zero-interest plans, there are real ways to cut costs if you’re proactive and strategic.
If you’re paying out of pocket—either because your treatment isn’t covered or your deductible is too high—you’re not out of options. Many clinics are willing to work with patients who ask the right questions. But you usually have to ask first.
Here are four strategies to help reduce your overall cost:
- Ask About Package Pricing: Most IV and injection clinics offer discounted rates if you commit to a full induction series (usually 6–8 sessions). A clinic charging $350 per session might offer a six-pack for $1,800—dropping the per-session cost to $300. Some even waive intake or monitoring fees if you prepay.
- Inquire About Sliding Scale: It’s rare, but some providers offer income-based pricing—especially smaller practices or those run by clinicians who also offer psychotherapy. It’s almost never advertised. You have to ask directly and be honest about your financial situation.
- Look Into Financing or Payment Plans: Some clinics partner with companies like CareCredit or offer internal payment plans with 0% interest if paid within a few months. Read the terms carefully—especially if a third-party lender is involved. These can work well if you can stick to the timeline.
- Negotiate Based On Your Schedule: High-volume clinics sometimes discount off-peak hours (early mornings, midweek slots) to fill gaps. Others may offer repeat patient discounts for booster sessions down the line. If you’re flexible, it’s worth asking.
The key here is simple but hard: you have to bring it up. Clinics rarely publish their discount structure. And some won’t offer anything unless you initiate the conversation. It’s uncomfortable—but it can save you thousands.
In the next section, we’ll talk about the costs that don’t show up on the website or in your first consultation—but hit you just as hard once treatment begins.
If you’re paying cash, asking the right questions could save you thousands. Package rates, sliding scale options, and quiet discounts exist—but most clinics won’t bring them up unless you do. Don’t wait for a deal to be offered. Ask.
How Do I Make The Smartest Financial Decision For Me?
For many patients, the smartest financial move isn’t waiting until everything lines up. It’s starting treatment with whatever resources you have now, even if that only gets you through the first 6–8 sessions. This section lays out how to think clearly about the financial tradeoffs, how to use early treatment results to unlock insurance support, and how to time your care to take advantage of subsidies and deductibles.
When you’re dealing with treatment-resistant depression, this isn’t just another expense to weigh against your vacation fund. This is about survival, functionality, and reclaiming your life. Here’s how to make the best financial decision with that reality in mind:
Prioritize Getting Started Over Perfect Planning
Start with what you can access right now. If you can afford 6-8 IV ketamine sessions ($2,550-$6,000), begin there even if you’re unsure about affording the entire protocol. The profound relief that 70%+ of patients experience in those first weeks can transform your ability to problem-solve, work, and advocate for yourself.
Remember: Depression itself is financially devastating. It’s not just about treatment costs – it’s about the cost of losing your job, your relationships, your housing, or worse. When weighing costs, factor in what continued depression is already costing you.
Create Strategic Access Points
Use IV or injection for rapid stabilization. These formats deliver faster, more complete relief than Spravato in the critical first weeks. Once stabilized, you’ll have more mental clarity to navigate insurance battles for longer-term coverage.
Leverage the “foot in the door” approach. Some patients start with self-pay IV ketamine, experience significant improvement, then use that documented response to convince insurance to cover Spravato maintenance – showing previous treatment response often strengthens your case.
Make Depression Recovery Your Temporary Financial Priority
Temporarily reallocate funds from retirement or savings. While normally inadvisable, treatment-resistant depression is a legitimate financial emergency. Successful treatment could add decades of productive earning to your life, far outweighing a temporary savings withdrawal.
Consider credit as a lifeline, not a burden. Using a 0% introductory credit card or CareCredit for initial treatments can bridge the gap until treatment enables you to work more effectively. Improved mental health typically leads to improved income potential.
Extract Maximum Value From Every Dollar
Identify clinics that bundle psychotherapy with ketamine. Combined treatment approaches yield substantially higher remission rates (up to 72% vs. 40-50% with ketamine alone). The added cost of therapy pays for itself through fewer required maintenance sessions later.
Seek clinics using precision medicine approaches. Some providers use biomarkers or genetic testing to personalize dosing protocols, potentially reducing the number of sessions needed to achieve remission.
Create a “Treatment First, Perfect Later” Plan
Focus on getting well enough to solve the money problem. Many patients find that after 6-8 sessions, they’ve regained enough function to either return to work, find better employment, or advocate more effectively with insurance companies.
Split your financial planning into emergency and recovery phases. Make separate plans for: (1) getting immediate relief, and (2) maintaining that relief once you’re functioning better. Different financial strategies apply to each phase.
The smartest financial decision isn’t always the cheapest one—it’s the one that gives you back your ability to earn, function, and build a future worth living.
Got Questions? Ask Me Directly.
Ketamine Therapy Cost FAQs
How much does a full course of ketamine therapy typically cost, and how do the costs differ between delivery methods?
A full 6-month course of ketamine therapy typically costs between $3,300 and $27,300, depending on which delivery method you choose. IV ketamine ranges from $4,675–$13,500 for 11–18 sessions, with a median cost of $7,975. Injection ketamine is the most affordable at $3,300–$6,050 for the same number of sessions.
Spravato nasal spray shows the widest cost variation. Without insurance, it’s the most expensive option at $16,800–$27,300 for 21 required sessions. With commercial insurance, that drops to $2,940–$9,450. If you qualify for both insurance coverage and the manufacturer’s assistance program, costs can fall dramatically to $0–$1,300.
Each method requires different session frequencies and medical monitoring, creating significant price differences. That means your treatment approach isn’t just a medical decision—it’s a financial one that impacts both your budget and treatment schedule.
What are the self-pay costs for ketamine therapy if insurance doesn’t cover anything, and which option is the least expensive?
Self-pay ketamine therapy without any insurance coverage costs between $3,300 and $27,300 for a complete treatment course. Injection ketamine is the least expensive option at $3,300–$6,050 for 11–18 sessions, with treatments priced at $300–$550 each. IV ketamine costs moderately more at $4,675–$13,500 total ($425–$750 per session).
Spravato nasal spray is substantially more expensive for self-pay patients, ranging from $16,800–$27,300 for the required 21 treatments. Each Spravato session costs $800–$1,300 when paying completely out-of-pocket.
These prices represent true treatment costs across the entire six-month protocol, including both initial intensive sessions and maintenance treatments. Price variations reflect differences in bioavailability, potency, and clinical monitoring requirements between methods. That means injection ketamine, while least expensive, may offer less medical supervision than the more costly IV or Spravato options.
Why is Spravato covered by some insurance plans, but IV and injection ketamine aren’t?
Spravato is covered by some insurance plans because it received FDA approval specifically for treatment-resistant depression in 2019. IV and injection ketamine, despite decades of research showing effectiveness, aren’t FDA-approved for depression and remain “off-label” treatments that insurance won’t touch.
This coverage disparity isn’t about effectiveness—it’s about regulatory pathways and profit incentives. Ketamine is an old generic drug with no patent protection, so pharmaceutical companies have no financial motivation to sponsor the billion-dollar FDA approval process. Spravato, however, is a patentable nasal spray containing only half of the ketamine molecule (S-ketamine), making it commercially viable.
The FDA lacks a pathway for approving generic drugs with strong independent evidence but no corporate sponsor. Even with over 80 randomized controlled trials supporting IV ketamine’s efficacy, without a company funding the formal approval process, insurance companies won’t cover it. That means many patients are priced out of what many clinicians consider the more effective option.
What would I pay if my insurance covers Spravato, and how does that compare to paying out of pocket for IV ketamine?
If your insurance covers Spravato, you’ll typically pay between $2,940 and $9,450 for the full 21-session protocol. That breaks down to about $140–$450 per session, with a median total cost around $6,195. In comparison, self-pay IV ketamine costs between $4,675 and $13,500 for 11 to 18 sessions, with a median cost of $7,975.
So Spravato with insurance can be either cheaper or more expensive than IV ketamine, depending on where you land within those ranges. But if you also qualify for Janssen’s manufacturer assistance program, your total Spravato cost can drop to just $0–$1,300—making it by far the most affordable option.
What other expenses should I expect besides the ketamine treatment itself, and how much do they add up to?
Beyond the treatment sessions themselves, there are several other costs you may need to plan for. Many clinics charge intake or consultation fees—typically $150 to $500—which are separate from your first session. Time off work can also become a major expense, especially with Spravato’s 21-session protocol that often requires at least 2 hours per visit.
If you don’t have paid leave, that’s income lost. Transportation is another factor. While some patients rely on family or friends, others may need to pay for Uber or Lyft to and from the clinic—potentially adding up over time. Childcare costs can also come into play, depending on your situation.
That means the real cost of ketamine therapy often extends beyond the price tag—logistics like time, transport, and support can quietly strain your budget if you’re not prepared.
What strategies can I use to lower the cost of ketamine therapy if I’m paying out-of-pocket, and do clinics offer any financial assistance options?
To lower out-of-pocket ketamine costs, first ask about package pricing—many clinics offer discounts of 10-20% when you commit to a full series (usually 6-8 sessions). This can reduce a $2,400 treatment series to around $1,800. Some clinics also offer sliding scale fees based on income or financial hardship, though you typically need to ask directly as these options are rarely advertised.
Financing through CareCredit or clinic payment plans with 0% interest is widely available. Scheduling flexibility can also save money, as some high-volume clinics discount off-peak appointment times to fill scheduling gaps.
For Spravato, check if you qualify for the manufacturer’s assistance program, which provides up to $8,150 in savings. Some patients use HSA/FSA funds for treatment, offering tax advantages that effectively provide a 22-37% discount depending on your tax bracket. In practice, combining these approaches often makes the difference between abandoning treatment and completing the full protocol.
Still have questions? The financial landscape of ketamine therapy is complex, but understanding your options is the first step toward making treatment accessible.
What Does Scientific Research Show About IV Ketamine’s Effectiveness For Depression?
I pulled together 33 systematic reviews from the last five years into one report—so you don’t have to rely on hype, guesses, or anecdotes. This is the highest level of real-world evidence we have.
Inside My Report You’ll Find
- What percent of patients enter remission—broken down by delivery method
- Which method is most effective—IV, injection, or Spravato nasal spray
- How fast ketamine can work to reduce or end symptoms
- Which combinations (like psychotherapy) may enhance response
- And a lot more…
Verified by the Platforms That Matter
This research summary report has been published across four trusted platforms that host peer-reviewed or open science content, including:
– Published ketamine research on Zenodo
– Ketamine evidence summary hosted on SSRN
– Scientific report on ketamine outcomes on Figshare
– Evidence-based ketamine therapy report on OSF
View the PDF Report Here:
My Personal Experience
Why I Chose Spravato—Even Though IV Ketamine Works Better
I’ve never had an IV ketamine infusion. Not once. Never sat in the chair, never watched the drip, never felt it hit. And yet if you’ve read this site, you’ve seen me banging the drum for IV ketamine like I’m their unpaid spokesperson.
It’s not hype. It’s the research. IV ketamine is 3 to 5 times more effective than Spravato. Faster, stronger, more flexible, and more reliable. You don’t need to take my word for it—systematic reviews say it loud and clear. So why didn’t I do it?
Because I didn’t know. Nobody told me. I didn’t understand that the delivery method mattered. I didn’t know about bioavailability or why 100% absorption through IV was so different from a nasal spray. I wasn’t even asking the right questions.
But even if I had known, I couldn’t have done it. I was broke. Completely broke. Insurance doesn’t cover IV infusions, and I was staring down $5,000–$7,000 out of pocket just to get started. It wasn’t an emotional decision. It was arithmetic. I didn’t have the money.
I almost didn’t do ketamine therapy at all. The first time I called my insurance company, the guy on the phone flat-out said they didn’t cover it. I gave up. Luckily, I called back. The second person knew more—and told me that Spravato was covered.
Even then, the costs were brutal. My share was going to be nearly $6,000. Still impossible. I was ready to walk away again.
Then someone told me about the manufacturer’s subsidy. I applied, got approved, and my out-of-pocket dropped to $10 per session. That changed everything.
I started Spravato. I got better. Went into remission in 6 weeks. And even though I’ve never had an IV infusion, I’ll keep writing about it—because people deserve the best version of treatment they can get.
And they deserve to know every option, not just the one that’s covered by insurance.
Clinical Evidence & Sources for This Page
These evidence summaries explain how much Spravato and other ketamine treatments can cost with and without insurance, from in-clinic IV infusions to at-home telehealth tablets. They link directly to economic evaluations, savings-program rules, and real-world pricing examples used to build the cost ranges and calculators on this page.
How much does Spravato cost without insurance? This NCBI health technology assessment reviews esketamine as a high-cost, in-clinic treatment and uses modeling to estimate drug and administration costs for patients and payers.
NCBI Bookshelf – Clinical and economic overview of esketamine
How much does Spravato cost without insurance? This PubMed-indexed analysis models the cost-effectiveness of adding esketamine to standard care, showing how drug price and clinic visits drive total treatment cost and value.
How much does Spravato cost without insurance? Harvard health economists at CHDS evaluate the cost-effectiveness of esketamine for treatment-resistant depression, comparing its high upfront price to expected gains in quality of life.
How much does Spravato cost with insurance? This study examines esketamine coverage policies, including prior authorization, patient cost-sharing, and how insurers’ decisions affect out-of-pocket costs.
How much does Spravato cost with insurance? Real-world claims data here describe approval rates, typical copays and deductibles, and the budget impact of covering Spravato for treatment-resistant depression.
How much does Spravato’s withMe Savings help? The official program requirements spell out eligibility rules, annual caps, and exclusions so you can estimate how much the copay card might reduce your Spravato bills.
How much does Spravato’s withMe Savings help? This Janssen withMe page walks patients through enrollment, verification of commercial insurance, and how savings are applied at the pharmacy or clinic.
How much does IV ketamine cost? Avest Ketamine & Wellness lists per-infusion prices for IV ketamine and nasal treatments, giving a concrete example of self-pay rates before insurance or discounts.
Avest Ketamine & Wellness – Example IV ketamine infusion pricing
How much does IV ketamine cost? NOMA Therapy’s cost overview breaks down typical price ranges for IV, nasal, and oral ketamine, plus factors like number of sessions and monitoring fees that shape the total bill.
How much does IV ketamine cost? Athena Care’s service page explains how ketamine for depression is delivered in-clinic, discusses insurance versus self-pay options, and outlines financial considerations for a full course of treatment.
Compounded pharmacy costs of oral/sublingual ketamine when a psychiatrist or physician writes the prescription. This review discusses compounded oral ketamine formulations, dosing, and pharmacy preparation, providing context for how medication and compounding practices contribute to overall cost.
Daily microdosing costs of oral/sublingual ketamine. Joyous publishes subscription-level pricing for low-dose daily ketamine, showing how at-home microdosing bundles medication, monitoring, and support into a monthly fee.
Macro dosing of oral/sublingual ketamine via telehealth. Smith Family MD outlines its at-home ketamine treatment protocol, including dose schedules, telehealth visit requirements, and example pricing so patients can anticipate program costs.
Smith Family MD – Telehealth macrodose ketamine protocol & pricing
Macro dosing of oral/sublingual ketamine via telehealth. Wondermed describes its comprehensive at-home ketamine program, detailing package pricing, what is included in the fee, and how costs compare to traditional in-clinic care.
Macro dosing of oral/sublingual ketamine via telehealth. NOMA Therapy explains how insurance may or may not cover at-home ketamine services and what patients can expect to pay out of pocket for macrodose programs.
Macro dosing of oral/sublingual ketamine via telehealth. Ketamine Central GA publishes detailed pricing for its ketamine treatments, offering another real-world benchmark for per-session and package costs.